SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-18-017897
Filing Date
2018-03-29
Accepted
2018-03-29 15:41:04
Documents
67
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv489075_10k.htm 10-K 746285
2 EXHIBIT 10.26 tv489075_ex10-26.htm EX-10.26 994933
3 EXHIBIT 23.1 tv489075_ex23-1.htm EX-23.1 3216
4 EXHIBIT 31.1 tv489075_ex31-1.htm EX-31.1 8458
5 EXHIBIT 31.2 tv489075_ex31-2.htm EX-31.2 8237
6 EXHIBIT 32.1 tv489075_ex32-1.htm EX-32.1 4527
7 EXHIBIT 32.2 tv489075_ex32-2.htm EX-32.2 4841
  Complete submission text file 0001144204-18-017897.txt   5716456

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT casi-20171231.xml EX-101.INS 928964
9 XBRL TAXONOMY EXTENSION SCHEMA casi-20171231.xsd EX-101.SCH 49334
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE casi-20171231_cal.xml EX-101.CAL 39105
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE casi-20171231_def.xml EX-101.DEF 288771
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20171231_lab.xml EX-101.LAB 348880
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20171231_pre.xml EX-101.PRE 337582
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20713 | Film No.: 18722784
SIC: 2836 Biological Products, (No Diagnostic Substances)